… on clinical outcomes in obese patients treated with cefepime. … dosing strategies on clinical
outcomes of obese patients … single-dose PK data in morbidly obese patients before bariatric …

… In conclusion, future studies should investigate what the optimal threshold for the AUC-guided
VAN dosing strategy should be in patients receiving TZP–VAN combination therapy. …

… , 79 intermittent infusion of piperacillin/tazobactam may … of morbidly obese patients with
obese patients, implying that lower loading doses would be an appropriate adjustment for patient …

… Examples might include statements such as “Insufficient evidence exists to provide
recommendations for drug dosing in morbidly obese patients” and “Patients receiving ECMO were …

… function, severe hypoalbuminemia, morbid obesity, and other … In general, the dosing of
lipophilic antibiotics in obese patients … A combination of piperacillin tazobactam with vancomycin …

… Piperacillin/tazobactam administered by continuous … of piperacillin/tazobactam in critically
ill adult patients with preserved renal function and to determine the empirical optimal dosing …

… Our case contrasts these reports of ARC as our patient had a low TBSA, was morbidly obese,
… on a rational TZP dosing strategy for non-critically ill burn patients with ARC and obesity. …

… ill severely obese patients (body mass index [BMI] of >35… patients receiving either conventional
or higher-than-conventional doses of meropenem or piperacillin/tazobactam, with dosing …

… treated with a standard dose of piperacillin/tazobactam (13.5 g/… recommended dose derived
from the noncommercial dosing … the use of TDM in morbidly obese patients, as drug CL may …

… With an anticipated change in dosing … dosing strategy in patients with and without obesity.
Accordingly, the primary objective of this study was to evaluate vancomycin total daily doses (…